Axa’s Clovis Oncology, Inc. CLVS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-20,600
| Closed | -$41.6K | – | 1247 |
|
|
2022
Q1 | $41.6K | Sell |
20,600
-380,700
| -95% | -$769K | ﹤0.01% | 1179 |
|
|
2021
Q4 | $1.09M | Buy |
+401,300
| New | +$1.09M | ﹤0.01% | 938 |
|
|
2021
Q1 | – | Sell |
-341,100
| Closed | -$1.64M | – | 1368 |
|
|
2020
Q4 | $1.64M | Buy |
341,100
+4,749
| +1% | +$22.8K | 0.01% | 886 |
|
|
2020
Q3 | $1.96M | Sell |
336,351
-12,549
| -4% | -$73.2K | 0.01% | 813 |
|
|
2020
Q2 | $2.36M | Buy |
+348,900
| New | +$2.36M | 0.01% | 787 |
|
|
2018
Q1 | – | Sell |
-15,700
| Closed | -$1.07M | – | 1436 |
|
|
2017
Q4 | $1.07M | Sell |
15,700
-19,700
| -56% | -$1.34M | ﹤0.01% | 985 |
|
|
2017
Q3 | $2.92M | Buy |
+35,400
| New | +$2.92M | 0.01% | 750 |
|
|
2016
Q1 | – | Sell |
-48,230
| Closed | -$1.69M | – | 1443 |
|
|
2015
Q4 | $1.69M | Buy |
48,230
+20,900
| +76% | +$731K | 0.01% | 810 |
|
|
2015
Q3 | $2.51M | Buy |
+27,330
| New | +$2.51M | 0.01% | 732 |
|
|
2015
Q1 | – | Sell |
-29,919
| Closed | -$1.68M | – | 1503 |
|
|
2014
Q4 | $1.68M | Buy |
29,919
+1,636
| +6% | +$91.6K | 0.01% | 839 |
|
|
2014
Q3 | $1.28M | Sell |
28,283
-182
| -0.6% | -$8.26K | 0.01% | 853 |
|
|
2014
Q2 | $1.18M | Sell |
28,465
-1,145
| -4% | -$47.4K | ﹤0.01% | 891 |
|
|
2014
Q1 | $2.05M | Buy |
29,610
+1,542
| +5% | +$107K | 0.01% | 764 |
|
|
2013
Q4 | $1.69M | Buy |
28,068
+1,396
| +5% | +$84.2K | 0.01% | 812 |
|
|
2013
Q3 | $1.62M | Buy |
+26,672
| New | +$1.62M | 0.01% | 785 |
|